Medy-Tox Inc. (KOSDAQ:086900)
South Korea · Delayed Price · Currency is KRW 85,000
+1,800 (2.16%)
Jun 12, 2026, 3:30 PM KST
Medy-Tox Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Medy-Tox stock has a consensus rating of "Hold" and an average price target of ₩124,750. The average 1-year stock price forecast is 46.76% higher than the current stock price, while the lowest is ₩90,000 (+5.88%) and the highest is ₩170,000 (+100.00%).
Price Target: ₩124,750 (+46.76%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medy-Tox stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 2 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 7 | 5 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
255.13B
from 247.29B
Increased by 3.17%
Revenue Next Year
299.61B
from 255.13B
Increased by 17.43%
EPS This Year
4.09K
from 2.37K
Increased by 72.59%
EPS Next Year
5.77K
from 4.09K
Increased by 41.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 255.1B | ||
| Avg | 255.1B | ||
| Low | 255.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.2% | ||
| Avg | 3.2% | ||
| Low | 3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 4,092.05 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 72.6% | ||
| Low | - |